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Abstract
Objectives—1) Investigate the use of optical reflectance spectroscopy to differentiate malignant
and non-malignant tissues in head and neck lesions; 2) Characterize corresponding oxygen tissue
biomarkers that are associated with pathologic diagnosis
Study Design—Prospective non-randomized clinical study
Setting—Tertiary VA Medical Center
Subjects and Methods—All patients undergoing panendoscopy with biopsy for suspected
head and neck cancer were eligible. Prior to taking tissue samples, the optical probe was placed at
three locations to collect diffuse reflectance data. These locations were labeled “tumor”,
“immediately adjacent”, and “distant normal tissue”. Biopsies were taken of each of these
respective sites. The diffuse reflectance spectra were analyzed, and biomarker specific absorption
data was extracted using an inverse Monte Carlo algorithm for malignant and non-malignant
tissues. Histopathological analysis was performed and used as the gold standard to analyze the
optical biomarker data.
Results—21 patients with mucosal squamous cell carcinoma of the head and neck were
identified and selected to participate in the study. Statistically significant differences in oxygen
saturation (p = 0.004) and oxygenated hemoglobin (p = 0.02) were identified between malignant
and non-malignant tissues.
Conclusion—Our study established proof of principle that optical spectroscopy can be used in
the head and neck areas to detect malignant tissue. Furthermore, tissue biomarkers were correlated
with a diagnosis of malignancy.
Introduction
Head and neck malignancies affect an estimated 50,000 people annually1. Early detection of
these malignancies results in improved outcomes. However, clinical differentiation between
malignant and non-malignant lesions of the upper aerodigestive tract can be challenging.
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Furthermore, prior surgery, trauma or radiation may make a clinical diagnosis even more
difficult. In these cases, biopsy of the lesion is performed to establish a diagnosis.
Based on a review at our institution between Jan 2009 and Dec 2009, 256 patients
underwent 305 biopsies, of which 192 samples were non-malignant. Thus, nearly 2 out of 3
clinically indicated biopsies were later pathologically determined to be non-malignant. This
statistic is likely representative of other tertiary care centers throughout the nation and
emphasizes the variability and uncertainty inherent in current clinical examinations.
In addition, surgical biopsy is not without its issues. Some lesions are difficult to access,
such as those located in the nasopharynx, oropharynx, hypopharynx and larynx. These
biopsies often require general anesthesia and biopsy in the operating room. According to the
American Hospital Directory, the national average charge of laryngoscopy with biopsy
(CPT 31535) is $1,176 per patient. Significant amounts of labor, facility, and monetary
resources are expended on patients who ultimately may have no malignancy. Consequently,
patient selection is important to minimize risks and costs and maximize yield. To address
this 63% negative biopsy rate at our institution, we’ve collaborated with the Duke
biomedical engineering department to explore an optical method as a potential tool to
improve patient selection.
This method is based on reflectance optical spectroscopy technology. Optical spectroscopy
is the use of light to evaluate the composition of materials. Spectroscopy is a broad field. In
this instance, diffuse reflectance spectroscopy using light in the visible UV-spectrum is
utilized. Reflected light is analyzed, providing absorption and scattering data that reflects
underlying tissue composition, particular tissue oxygen saturation, total hemoglobin
concentration and morphology.
Since carcinogenesis alters the structural and biochemical makeup of cells, the metabolic
needs of the tissues are altered, often leading to increased microvascularization and differing
oxygen utilization. This in turn affects optical properties of dysplastic and cancerous tissue.
Numerous studies 2–4 have demonstrated differences between normal tissue and tumor in
their respective diffuse reflectance spectra. These prior studies have relied on qualitative
waveform pattern matching across a broad wavelength range.
In contrast, Feld et al. have demonstrated similar quantitative optical spectroscopy
techniques in vitro5. Ramanujam et al. demonstrated the use of quantitative optical
spectroscopy in breast cancer6. Using a novel inverse Monte Carlo model7, specific
biomarker parameters were extracted from the optical reflectance data. This allowed for a
quantitative analysis to measure concentrations of these specific biomarkers and their
association with the pathologic diagnoses of disease. This study investigated the use of
optical reflectance spectroscopy and the scalable inverse Monte Carlo model to differentiate
malignant and non-malignant tissues specifically in head and neck lesions. Furthermore,
characterization of corresponding oxygen tissue biomarkers that predict pathologic diagnosis
was performed. The hypothesis was that optical reflectance spectroscopy can differentiate
malignant and non-malignant tissues in head and neck lesions. Furthermore, these
differences can be correlated with tissue oxygen biomarkers.
Subjects and Methods
This IRB approved study was open to all patients who were scheduled for panendoscopy
and biopsy for suspected head and neck cancer. Patients were approached and consented to
undergo non-invasive evaluation by the optical probe of sites to be biopsied. These sites
included “tumor”, “immediately adjacent to tumor” and “distant normal”.
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An optical spectroscopy probe was designed and manufactured to final form in the
laboratory of Dr. Nimmi Ramanujam at Duke University. This device is composed of optical
fibers that are epoxied together and covered by a stainless steel tube. Probe design details
have been described in prior publications by the Ramanujam group 6. In brief, light from a
450 watt Xenon source is passed through a monochromator, then down a collection of
optical fibers within a cable to the probe tip. The monochromator selects for wavelengths in
the range 350 – 600 nm. Light reflected off the tissues is then passed along a set of different
fibers within the cable to a spectrometer. A laptop computer is used to both control the light
source and spectrometer as well as analyze the incoming data. The fiber is 2mm in diameter
and the handheld probe is 5mm in diameter and is ensheathed in a stainless steel tube that is
amenable to sterilization.
Clinical Study Design
Consented patients had the optical probe placed on the surface of at least three sites
(“tumor”, “immediately adjacent to tumor” and “distant normal”). By this design, the
patients served as their own control. If biopsy of other areas was clinically indicated, then
the probe was also used to analyze that site prior to biopsy. Diffuse reflectance scans were
performed and data was collected. The data acquisition program allowed for multiple scans
to be obtained at the same site, and thus two to four optical scans were routinely obtained at
each biopsy site. Immediately after the scan, the probe was removed and the underlying
tissue was sampled with biopsy forceps such that the reflectance data could be directly
paired with the histopathological diagnosis.
Extraction of tissue biomarkers from optical probe data
A quantitative inverse Monte Carlo model was used to extract scattering and absorption
properties of the measured tissues7. Diffuse reflectance spectra measured from the tissue
were fit over the wavelength range of 450 to 600nm. Using this inverse Monte Carlo model,
concentrations of oxygenated hemoglobin (HbO2), deoxygenated hemoglobin (dHb), and
total hemoglobin (THb), as well as oxygen saturation (SO2%) were calculated in μM. These
biomarkers were extracted from the absorption coefficient spectra across all measured
subjects and sites. All fits and subsequent data analysis were performed using MATLAB
version 7.8, release 2009 (The MathWorks).
Statistical Analysis
For data analysis, tissue samples were grouped into two groups, malignant and non-
malignant, based on histopathological diagnosis. Mean concentrations per site for HbO2,
dHb, and THb and SO2% were then compared using unpaired Wilcox rank-sum test to
determine if there were statistically significant differences between malignant and non-
malignant tissues.
Results
A total of 21 patients were enrolled into the study, of which all were males During the study,
no adverse events were encountered. Patient demographics and biopsy locations are
represented in Table 1. A total of 266 scans were performed on 68 tissue biopsy sites, on
average four scans per site (range: 1–8 scans/site). Histopathologically, 43 biopsies were
normal tissue, 18 biopsies were tumor tissue and 7 biopsies demonstrated dysplasia. These 7
dysplastic specimens represented 23 total scans (Table 2). The dysplasia samples were
integrated into the non-malignant category for analysis. Figures A–C demonstrates the
calculated molar concentrations of the biomarkers deoxyhemoglobin (dHb), oxyhemoglobin
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(HbO2), and total hemoglobin (THb) for malignant and non-malignant samples. Figure D
shows the calculated tissue oxygen saturation (SO2%). Statistically significant differences
(defined as p < 0.05) were noted in the HbO2 concentration (p=0.02) and in SO2%
(p=0.004).
Discussion
Our study established proof of principle that optical spectroscopy can be used in head and
neck lesions to detect tissue biomarkers associated with malignancy. Data demonstrated that
tissue reflectance differences between malignant and non-malignant mucosal lesions of the
head and neck can be delineated with optical spectroscopy. Specifically, four biomarkers
were extracted from the reflectance data using an inverse Monte Carlo model and compared
between malignant and non-malignant tissues. Of these, the concentration of oxygenated
hemoglobin (HbO2) and the tissue oxygen saturation (SO2%) showed a statistically
significant difference.
Optical reflectance spectroscopy has previously been demonstrated to show different
reflectance, scatter and absorption patterns between malignant and non-malignant tissues 4,6.
This can be attributed to different structural and metabolic properties of the tissues in
question3. This is in line with many prior studies which have demonstrated significant
differences in oxygen tension in normal and metabolically active solid tumor tissues 8,9,10.
In the head and neck, prior studies focused on wave-form pattern matching to demonstrate
qualitative differences between normal and malignant tissues11,12. For example, Mallia et al.
have used laser induced autofluorescence and diffuse reflectance spectroscopy spectral
differences with curve-fitting to show differences between dysplastic tissues and squamous
cell carcinoma in oral cancers.
Furthermore, many study methods have relied on extrinsic contrast materials such as dyes or
stains, or more complex instrumentation in the case of laser induced autofluorescence. Tsui
et al. used direct fluorescence visualization to evaluate surgical margins in oral cavity
carcinoma13. Their study did highlight that optical technologies clearly define surgical
margins better than direct visualization. Other studies have used autofluorescence to
distinguish normal and abnormal tissues in the oral cavity, but no standardization has been
established2. These methodologies require additional skill sets or bulky equipment and may
rely on subjective interpretation. A quantitative approach, such as the methods described in
this study, may aid in defining surgical margins more accurately and objectively.
A limitation of this study is the small sample size. A larger study may better define and
identify other biomarkers. Also, it is recognized that determining dysplasia versus
malignancy is a more clinically relevant question. To address this, patients are being
recruited for a study to expand this dataset with the goal of establishing good specificity and
sensitivity data of optical biomarkers to distinguish dysplastic from malignant lesions.
Furthermore, we recognize different tissues within the head and neck, such as muscular,
mucosal and lymphoid, may likely have different optical signatures. As part of this
upcoming larger study, the goal would be to stratify findings by site. Other studies have also
identified probe pressure to be a variable that affects spectroscopy readings14,15. Probe
pressure may affect the contents of vascular channels, artificially reducing measured
hemoglobin or oxygen saturation. Standardizing the probe readings in the future will be
accomplished by integrating pressure sensors into the probe design.
This study suggests that there are specific biomarkers that can be identified via this method
of analyzing optical spectroscopy data. The clinical impact of this approach should improve
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patient selection for biopsy. The technology used to demonstrate this has the advantage of
being low-cost, portable, non-invasive and, most importantly, quantitative.
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(A–D) Box plots demonstrating differences between nonmalignant and malignant tissue in
terms of molar concentrations for (A) deoxygenated hemoglobin (dHb), (B) oxygenated
hemoglobin (HbO2), (C) total hemoglobin (THb), and (D) oxygen saturation (SO2%), as
determined by optical spectroscopy and an inverse Monte Carlo algorithm. Statistically
significant difference is noted in (B) HbO2 concentration and (D) SO2% (P = .019 and P = .
001, respectively).
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This is a representative pattern of reflectance from a single scan showing inherent
differences in reflectance between malignant and nonmalignant tissues.
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Table 1
Patient demographics and biopsy location
Patient Demographics









Base of Tongue 10 1
Tonsil 5 5
Oral Cavity 7 2
Tongue 5 1
Floor of Mouth 1 1
Other 1 0
Totals 50 18
Age in Years (Range)
Mean 60 (46–86)
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